Asian Hospital and Medical Center holds lecture on Immuno-thoracic Oncology

Lung cancer is the second most common cancer and the leading cause of cancer death anywhere in the world. In observance of the Lung Cancer Awareness Month, the Asian Hospital and Medical Center Asian Cancer Institute presented a lecture on Immuno-thoracic Oncology last November 10, 2015 in collaboration with Stephen Solarz International Fellowship Program.

Dr. David S. Schrump shared the latest developments in the field of thoracic oncology. Treatment appears to be more successful by employing latest guidelines designed to catch lung cancer early.

The Thoracic Oncology Unit at the Asian Hospital is made up of dedicated team of specialists who share the common goal of treating cancer in its state-of-the-art facility using multidisiplinary approach. The team works together to lead patients to the path of recovery with unmatched patient care.

Thoracic oncology refers to cancers that affect the chest area. They provide treatment to patients with lunch cancer, esophageal cancer, mesothelioma and other cancers located in the chest.

Tobacco-related carcinogenesis While smokers have the highest risk of developing Lung Cancer, the number of non-smokers exposed to environmental tobacco smoke contracting the disease is on the uprise. Lung tumorigenesis proceeds through different molecular mechanisms according to smoking status or extent of Tobacco smoke exposure. Passive smoking or breathing other people's tobacco smoke has been identified as a cause of lung cancer.

Lung resection can provide cure in some cancer cases that had been discovered early. the surgeical removal of a part of the lung may depend on the patient's diagnosis.

On Asian Hospital and Medical Center (AHMC)

Asian Hospital and Medical Center is a tertiary hospital which forms part of the Metro pacific Hospital, the largest private hospital group in the country being managed by Metro Pacific Investments Corporation.

Asian Cancer Institute (ACI) represents AHMC's global expertise in cancer care. Unveiled in July 2015, ACI offers a world-class integrative cancer care facility. It boasts of the most advance Radio Therapy services with its new TomoDirect Tomotherapy HDA-H Series Machine system that treat a full spectrum of patients without compromise. It also has an advanced High Dose Rate capable Brachytherapy system and MX16 Evo CT scans.

Visit to know more about the comprehensive, multidisiplinary services it offers.